This post first appeared on SEC Filings – Market Exclusive

EXACTUS, INC. (OTCMKTS:EXDI) Files An 8-K Regulation FD Disclosure
Item 7.01

Regulation FD Disclosure
On September 16, 2019, we released the updated investor presentation furnished herewith as Exhibit 99.1.
Section 9 – FINANCIAL STATEMENTS AND EXHIBITS
Item 9.01
Financial Statements and Exhibits
Exactus, Inc. Exhibit

To view the full exhibit click here

About EXACTUS, INC. (OTCMKTS:EXDI)

Exactus, Inc. (Exactus), formerly Spiral Energy Tech, Inc., is a life science company. The Company will develop and commercialize Point-of-Care (POC) diagnostics for measuring proteolytic enzymes in the blood based on a detection platform. The Company’s primary business focus will be the development and commercialization of the FibriLyzer and related technology licensed by Exactus. The Company’s products will employ a disposable test biosensor strip combined with a portable hand held detection unit that provides a result in approximately 30 seconds. The Company intends to file to gain regulatory approval and launch its products in the United States and Europe.

The post EXACTUS, INC. (OTCMKTS:EXDI) Files An 8-K Regulation FD Disclosure appeared first on Market Exclusive.

--
Copyright in text and images in this article belong to the original source.

This post first appeared on SEC Filings – Market Exclusive